Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.2850
+0.1150 (5.30%)
NASDAQ· Last Trade: Jul 23rd, 1:07 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors